Skip to main content

Table 3 Sensitivity analysis between the TyG trajectory and risk of hypertension

From: The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study

 

Low increasing

Moderate increasing

High stable

Unadjusted

   

 Sensitivity1

1 (reference)

2.43 (2.23–2.64)

3.87 (3.46–4.33)

 Sensitivity2

1 (reference)

2.44 (2.25–2.66)

3.85 (3.45–4.29)

 Sensitivity3

1 (reference)

1.48 (1.30–1.69)

2.73 (1.92–3.89)

 Sensitivity4

1 (reference)

2.31 (2.07–2.58)

3.21 (2.76–3.73)

Model 1

   

 Sensitivity1

1 (reference)

1.76 (1.61–1.92)

2.41 (2.14–2.71)

 Sensitivity2

1 (reference)

1.77 (1.62–1.93)

2.35 (2.10–2.64)

 Sensitivity3

1 (reference)

1.49 (1.31–1.70)

2.50 (1.76–3.57)

 Sensitivity4

1 (reference)

1.71 (1.52–1.91)

2.00 (1.71–2.34)

Model 2

   

 Sensitivity1

1 (reference)

1.37 (1.22–1.53)

1.69 (1.40–2.03)

 Sensitivity2

1 (reference)

1.36 (1.23–1.51)

1.67 (1.42–1.97)

 Sensitivity3

1 (reference)

1.40 (1.20–1.62)

2.51 (1.69–3.72)

 Sensitivity4

1 (reference)

1.41 (1.22–1.63)

1.58 (1.23–2.03)

  1. Sensitivity1: Diabetes mellitus and hypoglycemic agents are excluded
  2. Sensitivity2: multiple imputation
  3. Sensitivity3: propensity score matching
  4. Sensitivity4: participants who developed hypertension at visit 2 were excluded
  5. Model 1 was adjusted for baseline age and sex
  6. Model 2 further Adjusted for model 1 covariates plus baseline diabetes, smoking, systolic blood pressure, diastolic blood pressure, BMI, high density lipoprotein cholesterol, low density lipoprotein cholesterol, blood glucose, triglyceride, cholesterol, urea, uric acid, glomerular filtration rate